- $2.02bn
- $2.44bn
- $2.53bn
- 95
- 80
- 70
- 96
Annual balance sheet for HNI, fiscal year end - December 28th, USD millions except per share, conversion factor applied.
2021 January 2nd | 2022 December 31st | 2022 January 1st | 2023 December 30th | 2024 December 28th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 118 | 19.4 | 53.7 | 34.5 | 28.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 203 | 218 | 239 | 247 | 246 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 496 | 469 | 523 | 536 | 525 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 442 | 452 | 460 | 683 | 666 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,418 | 1,415 | 1,498 | 1,929 | 1,875 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 439 | 395 | 506 | 464 | 478 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 828 | 798 | 908 | 1,167 | 1,035 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 590 | 617 | 590 | 762 | 840 |
| Total Liabilities & Shareholders' Equity | 1,418 | 1,415 | 1,498 | 1,929 | 1,875 |
| Total Common Shares Outstanding |